Pfizer may sell Capsugel
This article was originally published in Scrip
Executive Summary
Pfizer is reviewing "strategic alternatives" for Capsugel, which may include a divestiture. Capsugel, a distinct business unit within Pfizer's Diversified Businesses segment, manufactures capsules and develops new drug delivery systems.